Clinical trial
A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone…
NCT00492700 · Association pour la Recherche sur les Maladies Hépatiques Virales, Other · Completed
Key facts
| NCT number | NCT00492700 |
|---|---|
| Title | A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis |
| Official title | A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis |
| Acronym | FLIRT |
| Lead sponsor | Association pour la Recherche sur les Maladies Hépatiques Virales, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Alcoholic Steatohepatitis |
| Intervention type | Drug |
| Interventions | rosiglitazone |
| Enrollment | 63 |
| Start date | Jan 1, 2003 |
| First posted | Jun 27, 2007 |
| Last update posted | Jun 27, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: